ENO2 and brain injury: The primary aim is to explore the timeframe of brain injury using brain injury biomarkers (S100B and NSE) as a baseline for the biochemical correlations (hypothesis A, Figure 1) in preterms with brain injury, in preterms without obvious brain injury and in healthy full-term neonates.